Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.320
+0.020 (0.87%)
At close: Jun 26, 2026, 4:00 PM EDT
2.400
+0.080 (3.45%)
After-hours: Jun 26, 2026, 6:51 PM EDT
Century Therapeutics Employees
Century Therapeutics had 78 employees as of December 31, 2025. The number of employees decreased by 72 or -48.00% compared to the previous year.
Employees
78
Change (1Y)
-72
Growth (1Y)
-48.00%
Revenue / Employee
n/a
Profits / Employee
-$1,381,859
Market Cap
418.42M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 78 | -72 | -48.00% |
| Dec 31, 2024 | 150 | -15 | -9.09% |
| Dec 31, 2023 | 165 | -19 | -10.33% |
| Dec 31, 2022 | 184 | -4 | -2.13% |
| Dec 31, 2021 | 188 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| Puma Biotechnology | 179 |
| Enanta Pharmaceuticals | 120 |
| Adlai Nortye | 109 |
| Artiva Biotherapeutics | 106 |
| Editas Medicine | 87 |
| Prelude Therapeutics | 79 |
| Eupraxia Pharmaceuticals | 49 |
IPSC News
- 18 days ago - Century Therapeutics presents new preclinical data for CNTY-813 - TheFly
- 18 days ago - New CNTY-813 Preclinical Data Demonstrate Durable Glucose Control, Immune Evasion Under Alloimmune Pressure, and Scalable Manufacturing at ADA 2026 - GlobeNewsWire
- 4 weeks ago - Century Therapeutics initiated with an Outperform at Mizuho - TheFly
- 6 weeks ago - Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors - GlobeNewsWire
- 6 weeks ago - Century Therapeutics reports Q1 EPS (11c), consensus (17c) - TheFly
- 6 weeks ago - Century Therapeutics Reports First Quarter Financial Results and Business Updates - GlobeNewsWire
- 6 weeks ago - Century Therapeutics Quarterly report: Q1 2026 - Filings
- 6 weeks ago - Century Therapeutics Earnings release: Q1 2026 - Filings